D. Sands (Warsaw, Poland), A. Bush (London, United Kingdom)
Potential difference test is valuable in the diagnosis of cystic fibrosis (CF)
A. Milanowski, R. Piotrowski, D. Sands (Warsaw, Poland)
|  |
Nontuberculous mycobacteria infection in patients with cystic fibrosis
Z. S. Uyan, R. Ersu, B. Karadag, F. Karakoc, K. Koksalan, E. Kiyan, E. Dagli (Istanbul, Turkey)
| |
Difficulties in diagnosing tuberculosis in patients with cystic fibrosis
I. K. Asherova, L. A. Vasiljeva (Jaroslavl, Russia)
| |
Macrolides in cystic fibrosis (CF); clinical experience
J. A. Kastelik, T. Patel, D. G. Peckham, C. Etherington, S. P. Conway (Leeds, United Kingdom)
| |
Anti-inflammatory therapy in cystic fibrosis: a comparative study in the treatment with nimesulide (selective cyclooxygenase-2 inhibitor) and clarithromycin (14-membered ring macrolide antibiotic)
G. V. Shmarina, A. L. Pukhalsky, N. J. Kashirskaja (Moscow, Russia)
| |
Early diagnostics of Burkholderia cenocepacia improves survival rate in patients with cystic fibrosis
D. Zemkova, P. Drevinek, V. Vavrova, P. Pohunek (Prague, Czech Republic)
| |
Bronchial hyperreactivity in cystic fibrosis
M. Bielecka-Zylbersztejn, A. Milanowski (Warsaw, Poland)
| |
The relationship between infectious process and bronchial hyperreactivity in CF children
N. Efimova, L. Jelenina, A. Orlova, T. Sologub (St Petersburg, Russia)
| |
Can new criteria for impaired fasting glucose (IFG) replace oral glucose testing (OGT) for cystic fibrosis-related diabetes (CFRD)?
M. Ballmann, C. Mueller-Brandes, M. Nastoll, R. W. Holl (Hannover, Ulm, Germany)
| |
Abnormal glycaemic control is common and easily detectable in children and adults with cystic fibrosis
S. Bell, W. Lenney, C. Pantin, P. J. Smith, S. Drummond, W. D. Carroll (Stoke-on-Trent, United Kingdom)
| |
Quantitative ultrasound in patients with cystic fibrosis in R.Macedonia
T. Jakovska-Maretti, S. Fustik-Naceva, L. Seckova, J. Gavrilovski, K. Jakovski (Skopje, Macedonia)
| |
Physical activity and quality of life are correlated with exercise tolerance in young adults with cystic fibrosis
C. Tardif, S. Pramil, C. Viacroze, E. Verin, C. Marguet, S. Dominique (Rouen, France)
| |
Chest physiotherapy adherence in cystic fibrosis Brasilian patients
S. R. Machado de Paula, M. A. Goncalves de Oliveira Ribeiro, J. D. Ribeiro, A. F. Ribeiro (Campinas, Brazil)
| |
Successful hepatitis B treatment with lamivudine and interferon-alpha in a patient with cystic fibrosis
A. Sauty, J. Mazza-Stalder, P. Mo Costabella, I. Pache, J. J. Gonvers (Lausanne, Switzerland)
| |
Cost of care of cystic fibrosis patients in Lodz district in Poland
I. Stelmach, A. Korzeniewska, M. Bobrowska, A. Soloniewicz, W. Stelmach (Zgierz, Lodz, Poland)
| |
The study of expectant life of St-Petersburg patients with cystic fibrosis (CF)
A. G. Tchermensky, T. E. Gembitskaya, L. A. Jelenina, A. V. Orlov (St Petersburg, Russia)
| |
Optimising treatment policies and improvement of care: impact on outcome in cystic fibrosis patients
L. L. Dracea, S. P. Conway, K. Brownlee, J. Taylor (Brasov, Romania; Leeds, United Kingdom)
| |
Prospective longitudinal evaluation of physical activities and pulmonary and nutritional status in children with cystic fibrosis
M. Ballmann, S. Junge, H. Stoppe (Hannover, Germany)
| |
Pulmonary fibrosis in children
J. Ziolkowski, J. Lange, M. Kulus, K. Krenke (Warsaw, Poland)
| |
One-year pulmonary safety and efficacy of inhaled insulin as adjunctive therapy in type 2 diabetes patients poorly controlled on oral agent monotherapy
J. G. Teeter, the Exubera® Phase III Study Group (Groton, United States Of America)
| |